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OBJECTIVES: Identifying factors associated with risk for eating disorders is important for 
clarifying etiology and for enhancing early detection of eating disorders in primary care. 
We hypothesized that autoimmune and autoinflammatory diseases would be associated 
with eating disorders in children and adolescents and that family history of these illnesses 
would be associated with eating disorders in probands.
METHODS: In this large, nationwide, population-based cohort study of all children and 
adolescents born in Denmark between 1989 and 2006 and managed until 2012, Danish 
medical registers captured all inpatient and outpatient diagnoses of eating disorders and 
autoimmune and autoinflammatory diseases. The study population included 930 977 
individuals (48.7% girls). Cox proportional hazards regression models and logistic 
regression were applied to evaluate associations.
RESULTS: We found significantly higher hazards of eating disorders for children and 
adolescents with autoimmune or autoinflammatory diseases: 36% higher hazard for 
anorexia nervosa, 73% for bulimia nervosa, and 72% for an eating disorder not otherwise 
specified. The association was particularly strong in boys. Parental autoimmune or 
autoinflammatory disease history was associated with significantly increased odds for 
anorexia nervosa (odds ratio [OR] = 1.13, confidence interval [CI] = 1.01–1.25), bulimia 
nervosa (OR = 1.29; CI = 1.08–1.55) and for an eating disorder not otherwise specified (OR = 
1.27; CI = 1.13–1.44).
CONCLUSIONS: Autoimmune and autoinflammatory diseases are associated with increased 
risk for eating disorders. Ultimately, understanding the role of immune system disturbance 
for the etiology and pathogenesis of eating disorders could point toward novel treatment 
targets.
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What’s KnoWn on this subject: Research evidence 
suggests that psychiatric disorders are associated 
with immune system disturbance. Autoimmune disease 
in adults is associated with a significantly increased 
hazard for subsequent eating disorders and vice versa.
What this study adds: In this study of ∼1 million
children and adolescents, we found associations 
between autoimmune and autoinflammatory disease 
and eating disorders. Parental history of autoimmune 
and autoinflammatory disease is associated with 
significantly increased risk for all eating disorders in 
their offspring.
to cite: Zerwas S, Larsen JT, Petersen L, et al. Eating Dis­
orders, Autoimmune, and Autoinflammatory Disease. Pedi-
atrics. 2017;140(6):e20162089
Compelling evidence1 suggests 
that immune system disturbance is 
associated with psychiatric disorders 
and contributes to the risk for their 
onset. Autoimmune processes are 
implicated in a number of psychiatric 
disorders.2 –5 Transdiagnostic 
psychiatric genomic investigations 
implicate immune-neuronal 
signaling pathways and suggest that 
autoimmune diseases and psychiatric 
disorders share etiological factors or 
pathogenic mechanisms.6
Research on immunologic and 
inflammatory markers associated 
with eating disorders has been 
inconclusive, with some researchers 
reporting a proinflammatory state, 7 – 12  
including the presence of auto-
antibodies against α-melanocyte-
stimulating hormone (a neuropeptide 
involved in appetite control) and 
autoantibodies that react with 
the neurohormones oxytocin and 
vasopressin, 13,  14 and others revealing 
few abnormalities.15, 16 Acute 
anorexia nervosa (AN) onset after 
a streptococcal infection and/or an 
autoimmune reaction (eg, pediatric 
autoimmune neuropsychiatric 
disorders associated with 
streptococcal infection leading to 
onset AN) has been documented, 
yielding recommendations for 
examining measures of antineuronal 
antibodies, such as AnAb and 
D8/17, to assess suspected pediatric 
autoimmune neuropsychiatric 
disorders associated with 
streptococcal infection leading to 
AN onset.17,  18 Population studies in 
Finland and the United Kingdom19,  20 
associated antecedent autoimmune 
diseases with a significantly 
increased risk for eating disorders, 
and data from a nationwide Swedish 
study revealed a bidirectional 
association between celiac disease 
and AN.21 In our previous work, 22 we 
revealed that adults with AN, perhaps 
because of low adipose tissue 
and high physical activity, have a 
distinct pattern of immune mediator 
expression (ie, low cytokines, 
elevated high-mobility group box 
1 protein) that differs from other 
somatic and psychiatric illnesses.23
We investigated associations 
between autoimmune and 
autoinflammatory diseases and 
eating disorders in youth in a 
nationwide, population-based 
cohort. Adolescence is the highest 
risk period for eating disorders, 
with a cumulative incidence of ∼1% 
for AN, ∼1% for bulimia nervosa 
(BN), and ∼1% for an eating 
disorder not otherwise specified 
(EDNOS) detected through medical 
surveillance.24 Early identification 
and intervention are critical and 
are associated with improved 
outcomes and decreased morbidity 
and mortality. Yet, eating disorders 
are often undetected in pediatric 
care. Even in European countries, 
only ∼25% of those with eating 
disorders ever receive treatment.25 
Understanding which children and 
adolescents are at an increased risk 
for eating disorders by examining 
antecedent medical status may aid in 
both detection and treatment.
Our aims were fourfold. First, to 
replicate and extend the Finnish 
findings, 19 we examined whether (1) 
autoimmune diseases (diseases of the 
adaptive immune system marked by 
aberrant B- or T-cell responses that 
lead to autoreactivity demonstrated 
by autoantibodies or T-cell reactivity 
to a self-antigen) were associated 
with increased hazard for subsequent 
eating disorders, and (2) whether 
eating disorders were associated 
with increased hazard for subsequent 
autoimmune disease. Second, 
we examined novel associations 
between autoinflammatory diseases 
(diseases of the innate immune 
system marked by activation of 
the inflammasome and elevated 
cytokine expression, especially 
interleukin-1) and eating disorders.26 
Third, sex-stratified analyses were 
performed when feasible. Finally, 
we examined whether the odds for 
eating disorders were elevated for 
youth with a family history (parents, 
full and half siblings, and cousins) of 
autoimmune and autoinflammatory 
diseases. By comparing family 
members with varying degrees of 
genetic relatedness (∼50% shared 
genes in biological parents and full 
siblings, ∼25% in half siblings, and 
∼12.5% in cousins) and with varying
shared environmental exposure,
we examined whether genetic or




Since 1968, every person living in 
Denmark has been assigned a unique 
personal identification number in the 
Danish Civil Registration System, 28  
enabling linkage across national 
registers. The Psychiatric Central 
Research Register (PCRR) and the 
National Patient Register (NPR) 
capture all inpatient psychiatric 
and general hospital admissions 
and, since 1995, all outpatient and 
emergency department visits.29 The 
registers include dates of admission 
and discharge, reason for contact, 
and main and auxiliary diagnoses30 
following a Danish version of 
the International Classification of 
Diseases, Eighth Revision (ICD-8) from 
1969 to 1993 and the International 
Classification of Diseases, 10th 
Revision (ICD-10) codes from 1994.31 
This study was approved by the 
Danish Data Protection Agency. 
Because all data were anonymized, 
informed consent was not required.
Population
All children born in Denmark to 
Danish-born parents between 
1989 and 2006 who were alive 
and residing in Denmark on their 
sixth birthday (N = 966 141; 48.7% 
girls) were included. Because of the 
limitations of the ICD-8 diagnoses 
of eating disorders, we included 
only individuals who could have 
received an incident ICD-10 eating 
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disorder diagnosis (starting in 
1994). Individuals born as part of a 
multiparous birth were excluded to 
reduce nesting (N = 35 144; 49.1% 
girls). The study population included 
930 977 children (48.7% girls). The 
study population and their relatives 
(parents, siblings, half siblings, and 
cousins) were followed until their 
date of death, emigration from 
Denmark, or December 31, 2012, 
whichever came first.
eating disorder assessment
We used the ICD-10 diagnoses in 
the PCRR or NPR as follows: AN 
(F50.0 AN; F50.1 atypical AN), 
BN (F50.2 BN; F50.3 atypical BN), 
and EDNOS (F50.8 other eating 
disorders; F50.9 eating disorder, 
unspecified). Diagnoses were not 
mutually exclusive (eg, AN and BN 
could be included at different times). 
Onset was age at first inpatient or 
outpatient contact with a diagnosis in 
the PCRR or NPR after age 6.
autoimmune and autoinflammatory 
disease assessment
Autoimmune and autoinflammatory 
diseases were defined by using 
the Danish ICD-8 and ICD-10 
diagnoses in the NPR (Supplemental 
Table 5). Age of onset was age 
at first inpatient or outpatient 
contact with an NPR diagnosis. 
We identified 50 autoimmune 
diseases or 10 autoinflammatory 
diseases (Supplemental Table 5). 
Because associations between eating 
disorders and autoimmune diseases 
could be driven by gastrointestinal 
factors, the autoimmune disease 
category also included a subcategory 
of diseases with a suspected presence 
of gastrointestinal involvement with 
no minimum age of onset.
statistical analyses
We used Stata version 13 (Stata Corp, 
College Station, TX) and adjusted for 
sex by means of separate underlying 
hazard functions using Cox 
proportional hazards regression for 
each of the following eating disorder 
outcomes: AN, BN, and EDNOS. 
All estimates were adjusted for 
calendar-time in the parametric part 
of the Cox model, and for age in the 
nonparametric part. Calendar year 
(categorized as 1995–1999, 2000–
2004, 2005–2009, and 2010–2012) 
and autoimmune disorder status 
were treated as time-dependent 
variables, whereas all other 
variables were considered time-
independent. Hazard of autoimmune 
and autoinflammatory disease were 
calculated in a similar manner, with 
eating disorder status as a time-
dependent exposure variable. Sex-
specific analyses were conducted 
when cell sizes were adequate. The 
combined follow-up time was 8.5 
million person-years for all survival 
analyses. The association between 
eating disorders in the proband and 
autoimmune and autoinflammatory 
diseases in family members was 
evaluated by calculating odds ratios 
(ORs) by using logistic regressions 
adjusted for sex and birth order 
(first, second, third, or fourth–18th). 
The presence of an eating disorder 
in the proband and the presence of 
autoimmune and autoinflammatory 
disease in family members was 
defined as a diagnosis at any time 
before December 31, 2012. Family 
members were grouped as parents, 
full siblings, maternal half siblings, 
paternal half siblings, and cousins. 
Because the ICD-10 diagnoses were 
only used to define eating disorders 
starting in 1994, the reverse 
analyses (eg, association between 
autoimmune and autoinflammatory 
disease in the proband and eating 
disorders in family members) could 
not be completed.
Results
hazard of eating disorders in 
individuals With autoimmune 
diseases
A total of 25 984 children and 
adolescents (54.2% girls) were 
diagnosed with an autoimmune or 
autoinflammatory disease. With the 
smoothed hazard curve, (Fig 1) we 
show that the risk for autoimmune 
but not autoinflammatory disease 
increases through childhood and 
adolescence. Of those diagnosed with 
autoimmune or autoinflammatory 
disease, 5617 (21.6%) had diseases 
with gastrointestinal involvement, 
3456 individuals (13.3%) had 
diseases with autoinflammatory 
processes, and 157 (0.6%) 
individuals had a subsequent eating 
disorder diagnosis (Table 1).
In Cox models, hazard ratios (HRs) >1 
indicate a higher probability of illness 
whereas ratios <1 indicate a lower 
probability of illness in comparison 
with unaffected individuals (Table 1). 
There was a 36% higher hazard for 
AN, 73% for BN, 72% for EDNOS, 
and 50% for any eating disorder 
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Hazard curves for eating disorders and autoimmune and autoinflammatory illnesses.
for children and adolescents with 
autoimmune or autoinflammatory 
diseases. Autoimmune diseases 
with gastrointestinal involvement 
were significantly associated with 
higher hazards for AN (74% higher 
hazard) and for EDNOS (148% higher 
hazard). Autoinflammatory diseases 
were associated with significantly 
increased hazard for EDNOS (179% 
higher hazard). In sex-stratified 
analyses (Table 2), male children and 
adolescents with any autoimmune 
disease had a 368% higher hazard 
for BN and 198% for EDNOS. Male 
children and adolescents with any 
autoinflammatory disease had a 
740% higher hazard for EDNOS. The 
hazards for male children have wide 
confidence intervals (CIs) and should 
be interpreted with caution.
hazard of autoimmune or 
autoinflammatory diseases in 
individuals With eating disorders
A total of 3914 adolescents received 
at least 1 eating disorder diagnosis 
(91.9% girls) during the study period. 
With the smoothed hazard curve  
(Fig 1), we show that the risk for all  
eating disorders increases through age 
14 and then remains high through 
the remainder of adolescence. 
Of those diagnosed with eating 
disorders, 2223 (56.3%) received 
an AN diagnosis, 727 (18.4%) a 
BN diagnosis, 1520 (38.5%) an 
EDNOS diagnosis, and 82 (2.1%) 
had a subsequent autoimmune or 
autoinflammatory diagnosis (Table 3).  
The percentages add to >100 because 
of overlapping categories.
AN was significantly associated 
with any subsequent autoimmune 
or autoinflammatory disease 
(64% higher hazard). EDNOS 
was significantly associated with 
any subsequent autoimmune or 
autoinflammatory disease (121% 
higher hazard) and autoimmune 
diseases with gastrointestinal 
involvement (97% higher hazard). 
In analyses stratified by sex, there 
were no male patients with eating 
disorders who had subsequent 
diagnoses of autoimmune or 
autoinflammatory disease.
hazard of eating disorders in 
individuals With a Family history of 
autoimmune or autoinflammatory 
diseases
Any family history of autoimmune 
or autoinflammatory disease 
was associated with significantly 
increased odds for AN, BN, and 
EDNOS (Table 4). Adolescents with 
parents who had autoimmune or 
autoinflammatory disease diagnoses 
had 13% higher odds of developing 
AN, 29% higher odds of developing 
BN, 27% higher odds of developing 
EDNOS, and 19% higher odds of 
developing any eating disorder. 
Individuals with full siblings who had 
autoimmune or autoinflammatory 
disease diagnoses had 48% higher 
odds of developing AN, 47% higher 
odds of developing EDNOS, and 
37% higher odds of developing 
any eating disorder. Autoimmune 
or autoinflammatory disease in 
maternal or paternal half siblings 
were not found to be related to 
eating disorder status in probands. 
Individuals with cousins who had 
autoimmune or autoinflammatory 
disease also had 20% higher odds 
of developing EDNOS and 17% 
higher odds of developing any eating 
disorder.
discussion
Autoimmune and autoinflammatory 
diseases are associated with 
significantly increased hazard for 
subsequent eating disorders, and 
eating disorders are associated with 
a significantly increased hazard for 
subsequent autoimmune disease. 
These results confirm previous 
findings19; however, different 
measurement of risk, younger 
age of participants, and different 
follow-up times preclude direct 
comparison. We extend previous 
science by demonstrating that 
youth with EDNOS also have an 
increased hazard for autoimmune 
and autoinflammatory disease, 19 
and we present the first documented 
association between eating disorders 
and autoinflammatory disease 
and between familial autoimmune 
disease and eating disorders in 
offspring.
What mediates the association 
between autoimmune or 
autoinflammatory disease and eating 
disorders remains unknown. Eating 
disorders are commonly associated 
with reward dysfunction, and neural 
inflammation can lead to changes 
in reward functioning including 
heightened reactivity to threat, 
increased sensitivity to punishment, 
and decreased connectivity in reward 
pathways.32 – 35 Why autoimmune 
illness is so strongly associated 
with increased hazard for eating 
disorders in male youth is unclear; 
although our results are preliminary, 
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table 1  HRs and 95% CIs of Subsequent Eating Disorders in All Children and Adolescents with Autoimmune and Autoinflammatory Diseases
No. Exposed AN BN EDNOS Any Eating Disorder
No. of 
Cases
HR 95% CI No. of 
Cases
HR 95% CI No. of 
Cases
HR 95% CI No. of 
Cases
HR 95% CI
Autoimmune 25 984 78 1.36** 1.09–1.71 40 1.73*** 1.26–2.39 70 1.72*** 1.36–2.19 157 1.50*** 1.27–1.75
Gastrointestinal 5617 17 1.74* 1.08–2.81 6 1.31 0.59–2.93 18 2.48*** 1.56–3.96 32 1.73** 1.22–2.45
Autoinflammatory 3456 10 1.31 0.70–2.44 5 1.67 0.69–4.02 15 2.79*** 1.68–4.64 26 1.87** 1.27–2.75
* P < .05; ** P < .01; *** P < .0001.
this finding has been documented 
previously.19 The development of 
eating disorders in boys may be more 




With our evidence, we suggest that 
eating disorders are associated 
with autoimmune disease with 
gastrointestinal involvement. 
EDNOS predicted a higher hazard of 
a subsequent autoimmune disease 
with gastrointestinal involvement. 
Moreover, autoimmune disease 
with gastrointestinal involvement 
predicted a higher hazard of 
subsequent AN and EDNOS. This 
association may be a diagnostic 
artifact caused by the differential 
diagnosis between eating disorders 
and gastrointestinal autoimmune 
diseases. AN and EDNOS may be 
misdiagnosed in individuals whose 
weight loss is due to malabsorption 
from gastrointestinal autoimmune 
illness such as Crohn disease or celiac 
disease. Gastrointestinal autoimmune 
diseases may also be misdiagnosed 
in patients with AN and EDNOS 
because of a misinterpretation of the 
underlying causes of food reactivity 
and delayed gastric emptying that 
are often a consequence of fasting 
behaviors.37,  38
Alternatively, proinflammatory 
cytokines produced by autoimmune 
diseases such as Crohn disease (eg, 
tumor necrosis factor α) lead to 
appetite suppression and weight 
loss, which may trigger eating 
disorder symptoms in vulnerable 
individuals.39,  40 In a case study, 39  
administration of an antitumor 
necrosis factor α treatment of 
a woman comorbid for Crohn 
disease and AN led to weight gain 
and decreased eating disorder 
symptomatology. Behaviorally, 
pain in response to eating and 
avoidance of foods that cause flare-
ups for gastrointestinal autoimmune 
disease could elicit eating disorder 
behavior or exacerbate symptoms in 
individuals with eating disorders. The 
associations between autoimmune 
disease and eating disorders are 
also not limited to gastrointestinal 
disorders, making misdiagnosis 
unlikely to be the sole explanation for 
the documented associations.
autoinflammatory disease
To our knowledge, this is the 
first study in which researchers 
document an association between 
autoinflammatory diseases and 
eating disorders. This fairly new 
classification of diseases is marked 
by diseases of the innate immune 
system and high levels of clinical 
inflammation. Genetic factors 
have been implicated in many 
autoinflammatory diseases, 41,  42 and 
researchers who conducted animal 
research suggest that the interplay 
between nutritional composition 
and intestinal microbiota may 
contribute to their onset. In 
these studies, 43 mice genetically 
predisposed to autoinflammatory 
disease and exposed to a low-fat 
diet experienced changes in their 
intestinal bacteria (increases in 
Prevotella), which led to the onset of 
autoinflammatory disease. Although 
little is known about the intestinal 
microbiota in patients with EDNOS, 
we44 have found that the intestinal 
microbiota of patients with acute 
AN is characterized by significantly 
lower taxa diversity than controls. 
Future research in this area should 
also include measures of nutritional 
composition and intestinal 
microbiota.
Family history: Genetic and 
environmental Factors
Autoimmune and autoinflammatory 
disease in parents is also associated 
with significantly increased odds for 
all eating disorders (AN, BN, EDNOS). 
Autoimmune and autoinflammatory 
disease in full siblings is also 
associated with significantly 
increased odds for eating disorders 
Zerwas et al


















































































































































































































































































































































































(AN and EDNOS in particular) and 
autoimmune and autoinflammatory 
disease in cousins is also associated 
with significantly increased odds 
for eating disorders (EDNOS in 
particular). Although the pattern 
of the association across varying 
degrees of relatedness can assist in 
making inferences about whether 
genetic or environmental factors 
explain the association, 27  
we found no clear patterns to 
make this distinction, potentially 
caused by low power because of 
the small number of half siblings. 
That autoimmune disease in cousins 
who share fewer environmental 
exposures was associated with eating 
disorders may, however, point to 
shared genetic risk. Supporting this 
interpretation is the discovery of 
the first genome-wide significant 
locus for AN on chromosome 12 
(rs4622308) in a region harboring a 
previously reported type 1 diabetes 
and autoimmune disease locus.45 
In addition, linkage disequilibrium 
score genetic correlations revealed 
intriguing negative genetic 
correlations (albeit nonsignificant) 
between AN and some autoimmune 
diseases (rheumatoid arthritis, 
ulcerative colitis, and Crohn disease), 
suggesting shared genetic effects 
with opposite directions of effect.46 
As sample sizes increase, we expect 
greater clarity in the association of 
eating disorders and autoimmune 
diseases on the genomic level. 
Moreover, genome-wide association 
data are not yet available for BN and 
EDNOS.
Importantly, unmeasured 
environmental mediators could 
explain the observed associations. 
These could be specific, shared 
environmental exposures (eg, 
nutrition, smoking exposure) that 
place family members at risk for both 
classes of illness or general, such as 
increases in familial stress because 
of illness or greater illness detection 
because of increased healthcare 
contact. Adequately-powered 
molecular genetic and twin designs 
are necessary to explicate these 
genetic and environmental pathways.
strengths and limitations
No private psychiatric hospitals 
exist in Denmark; hospital-based 
treatment is free of charge, and 
the nationwide registration of 
psychiatric disorders is almost 
complete. However, psychiatrists 
and psychologists do work in private 
practice and treat up to 20% of 
individuals with eating disorders.30 
These individuals may not be 
captured in the current study. The 
use of medical surveillance may 
have led to increased documented 
relative prevalence of AN in this 
sample in comparison with BN 
and EDNOS. Of those with eating 
disorders in the current study, 2233 
(57.1%) received an AN diagnosis, 
727 (18.6%) received a BN diagnosis, 
and 1520 (38.8%) received an 
EDNOS diagnosis, which differs 
from population-based surveys. It is 
likely that individuals with BN and 
EDNOS were under-detected, which 
could have affected our conclusions 
in 2 ways. First, patients with eating 
disorders who had inpatient and 
outpatient hospital-based contacts 
may be more medically compromised 
and more likely to also suffer from 
an autoimmune disease, thereby 
elevating the observed association. 
Second, undetected individuals with 
BN and EDNOS could have increased 
our statistical power to examine this 
association and thus, the observed 
associations are attenuated.
In addition, we only examined eating 
disorders in children and adolescents 
who were <24 years using the 
Danish registers because of the 
limitations of the ICD-8 diagnoses, 
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table 3  HRs and 95% CIs of Subsequent Autoimmune and Autoinflammatory Disease in Individuals with Eating Disorders
No. 
Exposed
Autoimmune Disease Gastrointestinal Autoinflammatory Disease
No. of 
Cases
HR 95% CI No. of 
Cases
HR 95% CI No. of 
Cases
HR 95% CI
AN 2223 47 1.64*** 1.23–2.18 13 1.34 0.77–2.30 ≤3 0.26 0.04–1.88
BN 727 11 1.31 0.73–2.37 ≤3 0.99 0.32–3.08 ≤3 1.07 0.15–7.64
EDNOS 1520 39 2.21*** 1.62–3.03 12 1.97* 1.12–3.48 ≤3 0.87 0.22–3.50
Any eating disorder 3946 82 1.68*** 1.35–2.09 24 1.43 0.96–2.15 4 0.63 0.24–1.69
* P < .05; *** P < .001.
table 4  OR (95% CI) of Eating Disorders in Individuals with Family History of Autoimmune and Autoinflammatory Diseases
AN BN EDNOS Any Eating Disorder
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Parents 1.13* 1.01–1.25 1.29** 1.08–1.55 1.27*** 1.13–1.44 1.19*** 1.10–1.28
Full siblings 1.48*** 1.21–1.80 1.03 0.69–1.54 1.47** 1.16–1.86 1.37*** 1.18–1.60
Maternal half siblings 0.92 0.55–1.53 1.37 0.68–2.76 1.26 0.76–2.11 1.19 0.86–1.66
Paternal half siblings 1.13 0.77–1.67 1.18 0.61–2.29 1.33 0.86–2.05 1.20 0.90–1.59
Cousins 1.11 0.99–1.25 1.10 0.89–1.36 1.20* 1.04–1.38 1.17** 1.07–1.27
* P < .05; ** P < .01; *** P < .001.
which may have attenuated HRs for 
both the antecedent and subsequent 
autoimmune and autoinflammatory 
diseases. The peak age of incidence 
for eating disorders occurs during 
adolescence, 24 but the period of 
incident risk for eating disorders 
extends across the lifespan. 
Although some autoimmune and 
autoinflammatory diseases onset in 
childhood and adolescence (eg, type 
1 diabetes, Crohn disease) and would 
be captured in these analyses, 47 others 
typically do not onset until midlife (eg, 
rheumatoid arthritis).48 As this study 
population ages, the HRs may intensify 
or attenuate commensurably. Like 
eating disorders, some autoimmune 
and autoinflammatory diseases may 
be under-detected in primary care, 
which may also have attenuated these 
associations.
Because of the limitations of 
the ICD-8 diagnoses, we were 
unable to examine potential 
associations between parental 
eating disorders and autoimmune 
and autoinflammatory diseases in 
offspring. Although we could have 
included parental diagnoses of eating 
disorders after the PCRR deployed 
the ICD-10 in 1994, we would have 
missed a large number of parents 
with an eating disorder history 
before 1994.
conclusions
The biological associations between 
autoimmune and autoinflammatory 
disease and eating disorders are 
becoming increasingly clear. Our 
findings support compelling lines of 
evidence from researchers suggesting 
that immune system disturbance 
is both comorbid with psychiatric 
disorders and can increase risk for 
illness.3 – 5,  19 Research into immune 
system dysfunction represents 
a novel lens to examine risk for 
eating disorders and could inform 
new treatments. Novel ideas are 
desperately needed in eating 
disorders; only 10% of adolescents 
receive treatment, the average 
duration of most eating disorders 
is >7 years, ∼25% of adolescents 
develop chronic illness, and there 
are no medications specifically for 
AN.49 Supported by our findings, we 
suggest further examination into the 
complex interplay between immune 
system disturbance, nutritional, 
and neuropsychiatric processes. 
Understanding the role of the 
immune system could explicate the 
etiology of eating disorders, aid early 
detection, personalize intervention, 
and ultimately improve outcomes.
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